This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Toyohiko Bunrin: Innovator in Pharmaceutical Preparations
Introduction
Toyohiko Bunrin is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing the bioavailability of medications, which is crucial for effective treatment outcomes.
Latest Patents
One of Toyohiko Bunrin's key patents is for a process for producing efonidipine hydrochloride preparations. This patent describes an amorphous solid dispersion of efonidipine hydrochloride that exhibits high intestinal absorbability. The process involves subjecting a mixture containing efonidipine hydrochloride, hydroxypropylmethylcellulose acetate succinate, and optionally a thermostabilizer to heat treatment or mechanochemical treatment. This innovative method allows for the production of solid dispersions without the need for organic solvents, making it advantageous for pharmaceutical manufacturing.
Career Highlights
Throughout his career, Toyohiko Bunrin has focused on improving drug formulations to enhance their effectiveness. His innovative approaches have led to advancements in the pharmaceutical industry, particularly in the area of drug absorption. With a patent portfolio that includes 1 patent, he continues to contribute to the field with his research and development efforts.
Collaborations
Toyohiko Bunrin has collaborated with notable colleagues in his field, including Misao Miyamoto and Toshio Okabe. These collaborations have fostered a productive environment for innovation and have led to significant advancements in pharmaceutical preparations.
Conclusion
Toyohiko Bunrin is a distinguished inventor whose work in pharmaceutical preparations has made a lasting impact on the industry. His innovative processes for enhancing drug absorption demonstrate his commitment to improving patient outcomes. His contributions continue to influence the field of pharmaceuticals, paving the way for future advancements.